By reducing hepatic SHBG production, hyperinsulinemia sustains elevated levels of bioavailable estrogens that far exceed what would be expected from obesity-associated aromatase activity alone. The gene discussed is SHBG; the disease is obesity due to melanocortin 4 receptor deficiency.